Potential mortality benefit from secondary prophylaxis following CMV treatment completion may be due to confounding by transplant organ type

Bradley J. Gardiner, Jennifer K. Chow, David R. Snydman

Research output: Contribution to journalLetterOtherpeer-review

2 Citations (Scopus)
Original languageEnglish
Article numbere13051
Number of pages2
JournalTransplant Infectious Disease
Volume21
Issue number2
DOIs
Publication statusPublished - Apr 2019

Cite this